Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Th17-mediated relapsing-remitting multiple sclerosis is nonresponsive to interferon-β1b].
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Acorda Therapeutics announces Hatch-Waxman extension of AMPYRA® (dalfampridine) sustained-release formulation patent
Episode 2 with Dr. Barbara Koppel on recommendations for cannabis in MS
Genes associated with T helper 17 cell differentiation and function.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Association between beta-interferon exposure and hospital events in multiple sclerosis.
Live Webcast: Assessing the Potential Impact of New and Emerging Disease-Modifying Therapies on the Initial Treatment and Comprehensive Management of Multiple Sclerosis
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
JC polyomavirus mutants escape antibody-mediated neutralization.
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Episode 15 with Professor Ludwig Kappos on the DECIDE trial of daclizumab versus interferon ë_-1a
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Epigenetics of Multiple Sclerosis: An Updated Review.
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Episode 24 with Professor Aksel Siva discussing asymptomatic MS
Episode 9 with Dr. Amit Bar-Or on how pediatric MS can illuminate early mechanisms of the disease
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.

Pages